ID
26689
Description
Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Unscheduled visit
Keywords
Versions (3)
- 9/21/17 9/21/17 -
- 10/23/17 10/23/17 -
- 12/22/17 12/22/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
October 23, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Unscheduled visit GSK study Chronic Coronary Heart Disease NCT00799903
Unscheduled visit GSK study Chronic Coronary Heart Disease NCT00799903
Description
PK sample collection performed at GSK request for sentinel event
Description
pharmacokinetic blood sample obtained
Data type
boolean
Description
date sample taken
Data type
date
Description
time sample taken
Data type
time
Description
date of last investigational product dose
Data type
date
Description
time of last investigational product dose
Data type
time
Description
Sample Identifier/Sample Number
Data type
text
No comments